Soyer, FerdaÖzdemir, Özgün ÖyküPolat, BengiEkenel, Nil Hazal2024-01-302024-01-3020242590-0889https://doi.org/10.1016/j.infpip.2023.100336https://hdl.handle.net/11147/14269Dear Editor, Nosocomial infections originating from commonly encountered pathogenic bacteria, notably Staphylococcus species, persist as a prominent global public health issue. This phenomenon exerts consequential impacts on both the well-being of patients and the healthcare personnel within hospital environments. Hospital-acquired infections from common bacteria like Staphylococcus remain a global public health concern. The European Centre for Disease Prevention and Control reports prevalence rates of 4.5% in the USA and 7.1% in Europe [1]. An estimated 8.9 million healthcare-associated infections occur annually in European hospitals and long-term care facilities [1]. According to the World Health Organization, although 10% of patients get healthcare-associated infections, at least a 30% reduction can be achieved through adequate infection prevention and control [2]. The efficacy of disinfection methodologies employed in healthcare institutions assumes critical significance in mitigating this threat.eninfo:eu-repo/semantics/openAccessBleaching agentAgar diffusionInfection controlStaphylococcus aureusStaphylococcus epidermidisLetter2-s2.0-8518181662610.1016/j.infpip.2023.100336